SGR-1505

· Schrödinger, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGR-1505, covering 2026-02-13 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of SGR-1505 in Mature B-Cell Neoplasms [Phase 1]